Cape Town | SAMRC Vice President Professor Jeffrey Mphahlele has been appointed Vice-Chair of The European and Developing Countries Clinical Trials Partnership (EDCTP) Association Board effective May 2019 until May 2021.
The EDCTP is an organisation that has fostered partnerships between European countries, developing countries, donors, and the pharmaceutical industry to enable clinical trials and the development of new medicines and vaccines against HIV/AIDS, tuberculosis, and malaria.
“I am honoured to take up the responsibility at EDCTP and hope that my work will assist in ensuring that global action against HIV/AIDS, tuberculosis, malaria and emerging diseases is accelerated and well-managed,” says Prof Mphahlele. “The multi-faceted collaborative approach between countries and public/private partnerships at the EDCTP is one that can result in the translation of research into clinical applications that are appropriate to the needs of developing countries.”
Prof Mphahlele is currently Vice-Chair of the EDCTP General Assembly, which ensures that all EDCTP activities are undertaken to achieve its statutory objectives, and that its resources are properly and efficiently managed. In his new role as Vice-Chair of the organisation’s Association Board, Prof Mphahlele will join a Board complement of five specialists and will be entrusted with the management of the Association as well as the supervision of the Secretariat on behalf of the General Assembly.
He is also an elected member of the Academy of Science of South Africa (ASSAf) and a National Research Foundation C1 rated researcher. He is affiliated to Sefako Makgatho Health Sciences University where he served as an academic for over 20 years in various capacities, trained, supervised and mentored several PhD and Masters students as his contribution to developing the next generation of African scientists. He continues to contribute to building the next generation of scientists through the SAMRC where he spearheaded the SAMRC’s Historically Disadvantaged Institutions programme that funds research capacity at eight of South Africa’s previously under-resourced universities.
Prof Mphahlele’s research interests include epidemiology of HIV, genomics of infectious diseases, vaccination control of infectious diseases (hepatitis B, rotavirus and human papillomaviruses) and strengthening immunisation services and policies. He serves on a number of governance structures and committees including the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), South African Health Products Regulatory Authority (SAHPRA), WHO Scientific Advisory Group of Experts (SAGE) Polio Working Group, National Advisory Group on Immunisation (NAGI) and South African National Task Force (NTF) for Laboratory Containment of Poliovirus.
The two-year appointment was announced at the EDCTP General Assembly at its meeting held in The Hague on 23 May 2019.
Tel: +27 71 214 5272